000 | 01597 a2200457 4500 | ||
---|---|---|---|
005 | 20250517064939.0 | ||
264 | 0 | _c20160926 | |
008 | 201609s 0 0 eng d | ||
022 | _a1936-2625 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFeng, Wenchang | |
245 | 0 | 0 |
_aEstablishment of stable multiple myeloma cell line with overexpressed PDCD5 and its proapoptosis mechanism. _h[electronic resource] |
260 |
_bInternational journal of clinical and experimental pathology _c2015 |
||
300 |
_a10635-43 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 |
_aApoptosis Regulatory Proteins _xmetabolism |
650 | 0 | 4 |
_aCaspase 3 _xmetabolism |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aDexamethasone _xpharmacology |
650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInhibitor of Apoptosis Proteins _xmetabolism |
650 | 0 | 4 |
_aMultiple Myeloma _xdrug therapy |
650 | 0 | 4 |
_aNeoplasm Proteins _xmetabolism |
650 | 0 | 4 | _aPhenotype |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xmetabolism |
650 | 0 | 4 | _aSignal Transduction |
650 | 0 | 4 | _aSurvivin |
650 | 0 | 4 | _aTransfection |
650 | 0 | 4 | _aUp-Regulation |
700 | 1 | _aFu, Yunfeng | |
700 | 1 | _aZhang, Yanan | |
700 | 1 | _aLv, Ben | |
700 | 1 | _aLi, Xin | |
700 | 1 | _aZhang, Fan | |
700 | 1 | _aGui, Rong | |
700 | 1 | _aLiu, Jing | |
773 | 0 |
_tInternational journal of clinical and experimental pathology _gvol. 8 _gno. 9 _gp. 10635-43 |
|
999 |
_c25496023 _d25496023 |